Hebrew University’s Dr. Michael Berger’s lab focuses on the antiviral immunity mediated by T-cell, which are the main cells that attach and kill virus-infected cells. His lab explores ways to manipulate these cells to make them more effective against viral infections. Findings from Dr. Berger’s lab show that T-cell immunity is impaired under low oxygen conditions characterize patients suffering from pulmonary diseases, and are being applied to COVID-19.
Related Posts
